IL152979A0 - Heterocyclic compounds - Google Patents
Heterocyclic compoundsInfo
- Publication number
- IL152979A0 IL152979A0 IL15297901A IL15297901A IL152979A0 IL 152979 A0 IL152979 A0 IL 152979A0 IL 15297901 A IL15297901 A IL 15297901A IL 15297901 A IL15297901 A IL 15297901A IL 152979 A0 IL152979 A0 IL 152979A0
- Authority
- IL
- Israel
- Prior art keywords
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000156936 | 2000-05-26 | ||
| PCT/JP2001/004400 WO2001090087A1 (fr) | 2000-05-26 | 2001-05-25 | Composes heterocycliques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL152979A0 true IL152979A0 (en) | 2003-06-24 |
Family
ID=18661643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15297901A IL152979A0 (en) | 2000-05-26 | 2001-05-25 | Heterocyclic compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US7144906B2 (ru) |
| EP (2) | EP1634876A3 (ru) |
| JP (1) | JP3591514B2 (ru) |
| KR (1) | KR100545507B1 (ru) |
| CN (1) | CN1238347C (ru) |
| AU (2) | AU2001258841B2 (ru) |
| BR (1) | BR0111199A (ru) |
| CA (1) | CA2410382A1 (ru) |
| HU (1) | HUP0302397A3 (ru) |
| IL (1) | IL152979A0 (ru) |
| MX (1) | MXPA02011609A (ru) |
| NO (1) | NO20025659D0 (ru) |
| RU (1) | RU2259361C2 (ru) |
| UA (1) | UA72625C2 (ru) |
| WO (1) | WO2001090087A1 (ru) |
| ZA (1) | ZA200209152B (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2525302A1 (en) * | 2003-05-12 | 2004-11-18 | David Bundle | Multivalent inhibitors of serum amyloid p component |
| EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
| EP1666479A1 (en) * | 2003-09-12 | 2006-06-07 | Nippon Shinyaku Co., Ltd. | Crystal of heterocyclic compound |
| OA13359A (en) * | 2004-01-09 | 2007-04-13 | Cadila Healthcare Ltd | 1,3-dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes. |
| CA2577668A1 (en) * | 2004-08-20 | 2006-02-23 | Cadila Healthcare Limited | Novel antidiabetic compounds |
| WO2006030892A1 (ja) * | 2004-09-17 | 2006-03-23 | Nippon Shinyaku Co., Ltd. | 複素環化合物の製造方法 |
| WO2007096261A2 (en) * | 2006-02-21 | 2007-08-30 | F. Hoffmann-La Roche Ag | Process for the preparation of dioxane derivatives |
| WO2008084962A1 (en) * | 2007-01-08 | 2008-07-17 | Seoul National University Industry Foundation | THIAZOLE COMPOUND (AS PPARδ) LIGAND AND PHARMACEUTICAL, COSMETIC AND HEALTH FOOD COMPRISED THEREOF |
| TW201022221A (en) | 2008-12-01 | 2010-06-16 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivatives containing thiazole ring and pharmaceutical use thereof |
| MX2011011614A (es) * | 2009-05-08 | 2011-11-18 | Pronova Biopharma Norge As | Acidos grasos poliinsaturados para el tratamiento de trastornos relacionados a las areas de los trastornos cardiovasculares, metabolicos e inflamatorios. |
| EP2483266B1 (en) * | 2009-10-01 | 2015-02-25 | Cadila Healthcare Limited | Compounds for the treatment of dyslipidemia and related diseases |
| US10882837B2 (en) * | 2017-01-24 | 2021-01-05 | Alphala Co., Ltd. | Amide compounds and use thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1473212A (en) * | 1974-02-27 | 1977-05-11 | Wyeth John & Brother Ltd | Thiazolylmethyl acetic acid derivatives methods for their preparation and compositions containing them |
| JPS60208971A (ja) * | 1984-03-30 | 1985-10-21 | Hisamitsu Pharmaceut Co Inc | 新規なオキサゾ−ル誘導体 |
| ZW19786A1 (en) * | 1985-10-17 | 1988-05-18 | Hoffmann La Roche | Heterocyclic compounds |
| FR2699172B1 (fr) | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5614544A (en) * | 1993-09-14 | 1997-03-25 | Takeda Chemical Industries, Ltd. | Oxazolidinedione derivatives and their use |
| WO1999031056A1 (fr) * | 1997-12-12 | 1999-06-24 | Toyama Chemical Co., Ltd. | Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant |
| EP1067109B1 (en) | 1998-03-10 | 2009-12-09 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| KR100613175B1 (ko) | 1998-08-27 | 2006-08-17 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 유도체 및 그 유도체를 유효 성분으로서함유하는 약제 |
| US6589969B1 (en) | 1998-10-16 | 2003-07-08 | Ono Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| GB0031109D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| GB0031107D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| IL158589A0 (en) * | 2001-05-15 | 2004-05-12 | Hoffmann La Roche | Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
| ATE347890T1 (de) * | 2001-08-31 | 2007-01-15 | Sanofi Aventis Deutschland | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren |
| US6716842B2 (en) * | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
-
2001
- 2001-05-25 JP JP2001586275A patent/JP3591514B2/ja not_active Expired - Fee Related
- 2001-05-25 RU RU2002135079/04A patent/RU2259361C2/ru not_active IP Right Cessation
- 2001-05-25 MX MXPA02011609A patent/MXPA02011609A/es not_active Application Discontinuation
- 2001-05-25 BR BR0111199-0A patent/BR0111199A/pt not_active IP Right Cessation
- 2001-05-25 WO PCT/JP2001/004400 patent/WO2001090087A1/ja not_active Application Discontinuation
- 2001-05-25 AU AU2001258841A patent/AU2001258841B2/en not_active Ceased
- 2001-05-25 AU AU5884101A patent/AU5884101A/xx active Pending
- 2001-05-25 EP EP05018610A patent/EP1634876A3/en not_active Withdrawn
- 2001-05-25 UA UA2002129620A patent/UA72625C2/ru unknown
- 2001-05-25 IL IL15297901A patent/IL152979A0/xx unknown
- 2001-05-25 HU HU0302397A patent/HUP0302397A3/hu unknown
- 2001-05-25 US US10/276,670 patent/US7144906B2/en not_active Expired - Fee Related
- 2001-05-25 CA CA002410382A patent/CA2410382A1/en not_active Abandoned
- 2001-05-25 EP EP01932267A patent/EP1295875A4/en not_active Withdrawn
- 2001-05-25 CN CNB018101402A patent/CN1238347C/zh not_active Expired - Fee Related
- 2001-05-25 KR KR1020027016023A patent/KR100545507B1/ko not_active IP Right Cessation
-
2002
- 2002-11-11 ZA ZA200209152A patent/ZA200209152B/en unknown
- 2002-11-25 NO NO20025659A patent/NO20025659D0/no not_active Application Discontinuation
-
2004
- 2004-02-17 US US10/781,433 patent/US7022723B2/en not_active Expired - Fee Related
- 2004-02-17 US US10/781,293 patent/US7030143B2/en not_active Expired - Fee Related
- 2004-02-17 US US10/781,475 patent/US6998412B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0302397A2 (hu) | 2003-11-28 |
| NO20025659L (no) | 2002-11-25 |
| AU5884101A (en) | 2001-12-03 |
| EP1634876A3 (en) | 2007-03-14 |
| NO20025659D0 (no) | 2002-11-25 |
| US20030166697A1 (en) | 2003-09-04 |
| US7030143B2 (en) | 2006-04-18 |
| CN1238347C (zh) | 2006-01-25 |
| KR20030019399A (ko) | 2003-03-06 |
| JP3591514B2 (ja) | 2004-11-24 |
| EP1634876A2 (en) | 2006-03-15 |
| US7022723B2 (en) | 2006-04-04 |
| HUP0302397A3 (en) | 2007-02-28 |
| KR100545507B1 (ko) | 2006-01-24 |
| WO2001090087A1 (fr) | 2001-11-29 |
| MXPA02011609A (es) | 2003-03-27 |
| CN1430612A (zh) | 2003-07-16 |
| US7144906B2 (en) | 2006-12-05 |
| ZA200209152B (en) | 2004-02-11 |
| US20040162325A1 (en) | 2004-08-19 |
| CA2410382A1 (en) | 2002-11-25 |
| US6998412B2 (en) | 2006-02-14 |
| AU2001258841B2 (en) | 2005-06-23 |
| US20050009785A1 (en) | 2005-01-13 |
| EP1295875A1 (en) | 2003-03-26 |
| US20050009892A1 (en) | 2005-01-13 |
| RU2259361C2 (ru) | 2005-08-27 |
| UA72625C2 (ru) | 2005-03-15 |
| EP1295875A4 (en) | 2004-05-06 |
| BR0111199A (pt) | 2003-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9929973D0 (en) | Heterocyclic compounds | |
| EP1349851A4 (en) | COMPOUNDS | |
| GB0123437D0 (en) | Heterocyclic compounds | |
| AU5884101A (en) | Heterocyclic compounds | |
| AU2001258841A1 (en) | Heterocyclic compounds | |
| AU2405002A (en) | Dehalogeno compounds | |
| GB9915510D0 (en) | Heterocyclic compounds | |
| GB9916218D0 (en) | Heterocyclic compounds | |
| GB9916216D0 (en) | Heterocyclic compounds | |
| GB9916213D0 (en) | Heterocyclic compounds | |
| GB0001972D0 (en) | Heterocyclic derivatives | |
| GB0001993D0 (en) | Heterocyclic derivatives | |
| GB0009452D0 (en) | PTP1B-Inhibiting heterocyclic derivatives | |
| GB9914173D0 (en) | New heterocyclic compounds | |
| GB0003631D0 (en) | Compounds | |
| GB0006800D0 (en) | Compounds | |
| GB0003608D0 (en) | Compounds | |
| GB0003599D0 (en) | Compounds | |
| GB0009456D0 (en) | Compounds | |
| GB0003609D0 (en) | Compounds | |
| GB0005574D0 (en) | Compounds | |
| GB0003600D0 (en) | Compounds | |
| GB0003598D0 (en) | Compounds | |
| GB0029343D0 (en) | Compounds | |
| GB0008728D0 (en) | Compounds |